Monoamine oxidase B (MAO-B) converts MPTP into MPP\( ^+ \), a neurotoxic metabolite responsible for Parkinsonism symptoms.
MPP\( ^+ \) selectively damages dopamine-producing neurons in the substantia nigra, mimicking Parkinson’s disease pathology.
MAO-B inhibitors can help prevent MPTP-induced neurodegeneration.